Thomas Adamkiewicz to Pneumococcal Infections
This is a "connection" page, showing publications Thomas Adamkiewicz has written about Pneumococcal Infections.
Connection Strength
1.524
-
Adamkiewicz TV, Yee MEM, Thomas S, Tunali A, Lai KW, Omole FS, Lane PA, Yildirim I. Pneumococcal infections in children with sickle cell disease before and after pneumococcal conjugate vaccines. Blood Adv. 2023 11 14; 7(21):6751-6761.
Score: 0.917
-
Adamkiewicz TV, Silk BJ, Howgate J, Baughman W, Strayhorn G, Sullivan K, Farley MM. Effectiveness of the 7-valent pneumococcal conjugate vaccine in children with sickle cell disease in the first decade of life. Pediatrics. 2008 Mar; 121(3):562-9.
Score: 0.309
-
Adamkiewicz TV, Sarnaik S, Buchanan GR, Iyer RV, Miller ST, Pegelow CH, Rogers ZR, Vichinsky E, Elliott J, Facklam RR, O'Brien KL, Schwartz B, Van Beneden CA, Cannon MJ, Eckman JR, Keyserling H, Sullivan K, Wong WY, Wang WC. Invasive pneumococcal infections in children with sickle cell disease in the era of penicillin prophylaxis, antibiotic resistance, and 23-valent pneumococcal polysaccharide vaccination. J Pediatr. 2003 Oct; 143(4):438-44.
Score: 0.227
-
Obert CA, Miller ML, Montgomery J, Adamkiewicz T, Tuomanen EI. Quinupristin-dalfopristin nonsusceptibility in pneumococci from sickle cell disease patients. Antimicrob Agents Chemother. 2007 Jan; 51(1):386-9.
Score: 0.070